Genzyme Recalls Lumizyme Vials Due to Incorrect or Missing Lot and Expiration Dates
Genzyme Corporation is recalling 24 vials of Lumizyme (alglucosidase alpha) because the packaging may have incorrect or missing lot and expiration dates.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which by definition is unlikely to cause adverse health consequences, and the hazard is limited to documentation/labeling issues.
Plain-English summary
Genzyme Corporation is recalling 24 vials of Lumizyme (alglucosidase alpha), 50 mg/vial, for intravenous infusion. The recall is limited to Lot # C5370C02 with an expiration date of 02/18. The product is distributed in Tennessee.
The recall was initiated due to a labeling defect where the lot number and/or expiration date on the packaging may be incorrect or missing. This is an FDA Class III recall, which indicates that the violation is not likely to cause adverse health consequences.
Healthcare providers and patients should check their inventory for this specific lot and expiration date. If the product is found, it should be quarantined and not administered until further notice. Patients should contact their healthcare provider for guidance on alternative treatment options if necessary.
The recalled product
- Product
- LUMIZYME (ALGLUCOSIDASE ALFA)
- Brand
- LUMIZYME
- Manufacturer
- Genzyme Corporation
- Category
- Drug — Prescription Biologic
- Hazard
- Affected units
- 24
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # C5370C02
- Exp. 02/18
Distribution
Distributed in 1 state:
Related recalls
Same manufacturer · Genzyme Corporation
See all →- LowGenzyme Recalls Clolar Injection Due to Missing Package Insert
FDA (Drugs) · 2017-11-22
- SevereGenzyme Recalls Thyrogen Injection Vials Due to Glass Particulate Matter
FDA (Drugs) · 2016-03-09
- SevereGenzyme Recalls Thyrogen Due to Glass Particles Found in Product
FDA (Drugs) · 2016-03-09
- HighGenzyme Recalls Seprafilm Adhesion Barrier Packs Due to Packaging Defect
FDA (Devices) · 2012-06-27
- HighGenzyme Recalls Seprafilm Adhesion Barrier Due to Packaging Sterility Risk
FDA (Devices) · 2012-06-27
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02